Search research articles
Contact Us
Filters
Showing results (61-70 of 189) with videos related to
Page
of 19
Sort By:
Haematologica
|
June 7, 2007
TACI expression is associated with a mature bone marrow plasma cell signature and C-MAF overexpression in human myeloma cell lines
Jérôme Moreaux, Dirk Hose, Michel Jourdan, et al.
British Journal of Haematology
|
March 21, 2009
Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cells
Caroline Bret, Dirk Hose, Thierry Reme, et al.
Blood Cancer Journal
|
February 17, 2018
Upregulation of FOXM1 in a subset of relapsed myeloma results in poor outcome
Chunyan Gu, Carol Holman, Ramakrishna Sompallae, et al.
Leukemia
|
November 13, 2019
Cytogenetic subclone formation and evolution in progressive smoldering multiple myeloma
Maximilian Merz, Thomas Hielscher, David Schult, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 2013
Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load
Kai Neben, Anna Jauch, Thomas Hielscher, et al.
Cancer
|
April 12, 2013
Autologous retransplantation for patients with recurrent multiple myeloma: a single-center experience with 200 patients
Leopold Sellner, Christiane Heiss, Axel Benner, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 17, 2011
Lenalidomide enhances antigen-specific activity and decreases CD45RA expression of T cells from patients with multiple myeloma
Brigitte Neuber, Isabelle Herth, Claudia Tolliver, et al.
Haematologica
|
December 22, 2010
A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines
Jérôme Moreaux, Bernard Klein, Régis Bataille, et al.
Immunological Reviews
|
April 21, 2006
Microarray-based understanding of normal and malignant plasma cells
John De Vos, Dirk Hose, Thierry Rème, et al.
JCO Precision Oncology
|
July 10, 2024
Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated With Bortezomib-Based Induction, High-Dose Therapy and Autologous Stem Cell Transplantation
Manuela Hummel, Thomas Hielscher, Martina Emde-Rajaratnam, et al.
Page
of 19
Search research articles
Search
Showing results (61-70 of 189) with videos related to
Sort By:
Page
of 19
Haematologica
|
June 7, 2007
TACI expression is associated with a mature bone marrow plasma cell signature and C-MAF overexpression in human myeloma cell lines
Jérôme Moreaux, Dirk Hose, Michel Jourdan, et al.
British Journal of Haematology
|
March 21, 2009
Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cells
Caroline Bret, Dirk Hose, Thierry Reme, et al.
Blood Cancer Journal
|
February 17, 2018
Upregulation of FOXM1 in a subset of relapsed myeloma results in poor outcome
Chunyan Gu, Carol Holman, Ramakrishna Sompallae, et al.
Leukemia
|
November 13, 2019
Cytogenetic subclone formation and evolution in progressive smoldering multiple myeloma
Maximilian Merz, Thomas Hielscher, David Schult, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 2013
Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load
Kai Neben, Anna Jauch, Thomas Hielscher, et al.
Cancer
|
April 12, 2013
Autologous retransplantation for patients with recurrent multiple myeloma: a single-center experience with 200 patients
Leopold Sellner, Christiane Heiss, Axel Benner, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 17, 2011
Lenalidomide enhances antigen-specific activity and decreases CD45RA expression of T cells from patients with multiple myeloma
Brigitte Neuber, Isabelle Herth, Claudia Tolliver, et al.
Haematologica
|
December 22, 2010
A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines
Jérôme Moreaux, Bernard Klein, Régis Bataille, et al.
Immunological Reviews
|
April 21, 2006
Microarray-based understanding of normal and malignant plasma cells
John De Vos, Dirk Hose, Thierry Rème, et al.
JCO Precision Oncology
|
July 10, 2024
Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated With Bortezomib-Based Induction, High-Dose Therapy and Autologous Stem Cell Transplantation
Manuela Hummel, Thomas Hielscher, Martina Emde-Rajaratnam, et al.
Page
of 19